1
LI Yun Long, COMBS Andrew P, YUE Eddy W, MADUSKUIE JR Thomas P, SPARKS Richard B: N-(1-(PHÉNYL SUBSTITUÉ)ÉTHYL)-9H-PURIN-6-AMINES EN TANT QUINHIBITEURS DE PI3K, N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS. INCYTE CORPORATION, LI Yun Long, COMBS Andrew P, YUE Eddy W, MADUSKUIE JR Thomas P, SPARKS Richard B, GODDARD Christine A, June 28, 2012: WO/2012/087881 (18 worldwide citation)

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based diso ...


2
Yun Long Li, Andrew P Combs, Eddy W Yue, Thomas P Maduskuie Jr, Richard B Sparks: N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors. Incyte Corporation, Fish & Richardson P C, August 4, 2015: US09096600 (3 worldwide citation)

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based diso ...


3
Yun Long Li, Andrew P Combs, Eddy W Yue, Thomas P Maduskuie, Richard B Sparks: N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors. Incyte Holdings Corporation, Incyte Corporation, Fish & Richardson P C, December 27, 2016: US09527848 (2 worldwide citation)

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based diso ...


4
Yun Long Li, Andrew P Combs, Eddy W Yue, Thomas P Maduskuie JR, Richard B Sparks: N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors. June 21, 2012: US20120157430-A1

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based diso ...


5

6
N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS. INCYTE CORPORATION, October 8, 2015: US20150284390-A1

The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based diso ...